1. Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey 
Maura Marcucci, MD, Gregory Y.H. Lip, MD, Robby Nieuwlaat, PhD, Ron Pisters, PhD, Harry J.G.M. Crijns, MD, Alfonso Iorio, MD 
The American Journal of Medicine 
Volume 127, Issue 10, Pages e2 (October 2014)
DOI: /j.amjmed
Copyright © 2014 Elsevier Inc. Terms and Conditions

2. Figure 1
Cardioembolic and bleeding risk scores co-distribution. A, CHADS2 and HAS-BLED scores. B, CHADS2 and HAS-BLED risk categories. C, CHA2DS2-VASc and HAS-BLED scores. D, CHA2DS2-VASc and HAS-BLED risk categories. Red line: median of HAS-BLED scores. CHADS2 = Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack; CHA2DS2-VASc = Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack, Vascular disease, Age 65-75, Sex category i.e. females; HAS-BLED = Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (>65 years), Drugs/alcohol concomitantly.
The American Journal of Medicine  , e2DOI: ( /j.amjmed )
Copyright © 2014 Elsevier Inc. Terms and Conditions

3. Supplementary Figure 1
Cardioembolic and bleeding risk scores co-distribution according to antithrombotic therapy prescribed at discharge. (A) CHADS2 and HAS-BLED. (B) CHA2DS2-VASc and HAS-BLED. Median of HAS-BLED scores (red line). AP = antiplatelet agent; CHADS2 = Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack; CHA2DS2-VASc = Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack, Vascular disease, Age 65-75, Sex category i.e. females; HAS-BLED = Hypertension, Abnormal renal/liver function, Stroke, Bleeding history or predisposition, Labile international normalized ratio, Elderly (>65 years), Drugs/alcohol concomitantly; No = no therapy; VKA = vitamin K antagonist.
The American Journal of Medicine  , e2DOI: ( /j.amjmed )
Copyright © 2014 Elsevier Inc. Terms and Conditions